BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11506494)

  • 1. Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status.
    Milde-Langosch K; Goemann C; Methner C; Rieck G; Bamberger AM; Löning T
    Br J Cancer; 2001 Aug; 85(4):546-51. PubMed ID: 11506494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
    Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
    Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
    Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status.
    Jares P; Rey MJ; Fernández PL; Campo E; Nadal A; Muñoz M; Mallofré C; Muntané J; Nayach I; Estapé J; Cardesa A
    J Pathol; 1997 Jun; 182(2):160-6. PubMed ID: 9274525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor status in female breast cancer: RT-PCR and Western blot studies.
    Bryś M; Wójcik M; Romanowicz-Makowska H; Krajewska WM
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):85-90. PubMed ID: 11862478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pRB2/p130 target genes in non-small lung cancer cells identified by microarray analysis.
    Russo G; Claudio PP; Fu Y; Stiegler P; Yu Z; Macaluso M; Giordano A
    Oncogene; 2003 Oct; 22(44):6959-69. PubMed ID: 14534545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma.
    Li SF; Shiozawa T; Nakayama K; Nikaido T; Fujii S
    Cancer; 1996 Jan; 77(2):321-9. PubMed ID: 8625241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of estrogen and progesterone receptor subtypes in human endometrial carcinoma tissues].
    Liao QP; Wu C; Zheng H; Yu L
    Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):752-5. PubMed ID: 16324249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer.
    Baldi A; Esposito V; De Luca A; Fu Y; Meoli I; Giordano GG; Caputi M; Baldi F; Giordano A
    Clin Cancer Res; 1997 Oct; 3(10):1691-7. PubMed ID: 9815552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
    Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
    Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression analysis of the estrogen and progesterone receptors in endometrial carcinomas.
    Olech-Fudali E; Chibowski D; Skomra D; Walczyna B
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():319-25. PubMed ID: 11977333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression.
    Jazaeri AA; Nunes KJ; Dalton MS; Xu M; Shupnik MA; Rice LW
    Oncogene; 2001 Oct; 20(47):6965-9. PubMed ID: 11687977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of RB and RB2/P130 genes in marrow stromal stem cells plasticity.
    Jori FP; Napolitano MA; Melone MA; Cipollaro M; Cascino A; Giordano A; Galderisi U
    J Cell Physiol; 2004 Aug; 200(2):201-12. PubMed ID: 15174090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease?
    Bird PA; Hill AG; Houssami N
    Ann Surg Oncol; 2008 Jul; 15(7):1983-8. PubMed ID: 18408976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogen regulated gene expression in normal and malignant endometrial tissue.
    O'Toole SA; Dunn E; Sheppard BL; Sheils O; O'Leary JJ; Wuttke W; Seidlova-Wuttke D
    Maturitas; 2005 Jun; 51(2):187-98. PubMed ID: 15917160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas.
    Reich O; Regauer S; Urdl W; Lahousen M; Winter R
    Br J Cancer; 2000 Mar; 82(5):1030-4. PubMed ID: 10737385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oestrogen receptor beta expression and depth of myometrial invasion in human endometrial cancer.
    Takama F; Kanuma T; Wang D; Kagami I; Mizunuma H
    Br J Cancer; 2001 Feb; 84(4):545-9. PubMed ID: 11207052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
    Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G
    Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.